JCM
CVS icon

Julex Capital Management’s CVS Health CVS Stock Holding History

Julex Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8
Closed -$431 – 156
2019
Q1 		$431 Hold
8
– – ﹤0.01% 145
2018
Q4 		$0 Buy
+8
New +$597 ﹤0.01% 115

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Julex Capital Management's CVS Position: Q2 2019 in Review

Julex Capital Management sold out of CVS Health (CVS) in Q2 2019, closing a stake of 8 shares — an estimated $431 sold.

Julex Capital Management first reported a position in CVS in Q4 2018 and held it in 2 quarters. The position peaked at $431 in Q1 2019. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

  • Julex Capital Management reported no remaining CVS Health position as of Q2 2019 after selling out during the quarter.
  • Julex Capital Management sold 8 CVS Health shares in Q2 2019, an estimated $431.
  • Julex Capital Management first reported a position in CVS Health in Q4 2018 and held it in 2 quarters.
  • Julex Capital Management's CVS Health position peaked at $431 in Q1 2019.
  • 1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Julex Capital Management's 13F filing for Q2 2019, filed 29 Oct 2019.